AI offers promise in the realm of chronic disease management, including diabetes, obesity, and PCOS, but must be approached with caution.

Mild cognitive impairment (MCI) and dementia pose significant health challenges in aging societies, emphasizing the need for accessible, cost-effective, and noninvasive diagnostic tools.

Microsoft is transforming its AI research capabilities into enterprise-grade infrastructure with the limited preview launch of enhanced agent support in Azure AI Foundry.